From the HY results presentation issued at the end of February this year...
"Research and development continues to be a cornerstone of the future growth of the Company."
So while Coris R&D may reduce, that's not the whole story.
Ann: Nanosonics Announces FDA Regulatory Submission for CORIS, page-6
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.46 |
Change
-0.080(2.26%) |
Mkt cap ! $1.063B | |||
| Open | High | Low | Value | Volume |
| $3.57 | $3.58 | $3.45 | $576.7K | 164.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 9092 | $3.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.47 | 8563 | 15 |
View Market Depth
| Last trade - 11.27am 13/09/2024 (20 minute delay) ? |
| NAN (ASX) Chart |